Premium
Loss of G3BP1 suppresses proliferation, migration, and invasion of esophageal cancer cells via Wnt/β‐catenin and PI3K/AKT signaling pathways
Author(s) -
Zhang LiNa,
Zhao Lei,
Yan XinLong,
Huang YingHui
Publication year - 2019
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.28648
Subject(s) - pi3k/akt/mtor pathway , cancer research , protein kinase b , wnt signaling pathway , biology , cell growth , gene silencing , axin2 , gene knockdown , cell migration , microbiology and biotechnology , signal transduction , cell , cell culture , biochemistry , genetics , gene
Accumulating evidence suggests that Ras GTPase‐activating protein SH3 domain‐binding protein 1 (G3BP1) is very crucial to regulate tumorigenesis and metastasis. Recently, many research works have suggested that G3BP1 is overexpressed in many human cancers including esophageal cancer. Nevertheless, the functional roles of G3BP1 in esophageal cancer are still unknown. Here, the results suggested that silencing of G3BP1 inhibited proliferation, migration, and invasion of esophageal cancer cells, whereas overexpression of G3BP1 led to opposite effects on the growth and metastasis. Surprisingly, G3BP1‐depletion had no effect on cell death but caused the arrest of cell cycle in the G 0 /G 1 phase and increased the levels of p53 and p21. In addition, loss of G3BP1 led to a significant elevation of E‐cadherin and decrease of N‐cadherin, Vimentin, Snail, MMP‐9, and MMP‐2. Mechanistically, loss of G3BP1 dramatically suppressed Wnt‐stimulated T‐cell factor/lymphoid enhancer factor (TCF/LEF) transcription factor activity and downregulated its target genes including c‐Myc, Axin2, and cyclin D1. Moreover, knockdown of G3BP1 downregulated the expression levels of p‐PI3K, p‐AKT, and p‐GSK‐3β, but the total PI3K, AKT, and GSK‐3β were not changed. Furthermore, our data proved that the promoting effects of G3BP1‐overexpression on cell proliferation, migration, and invasion could be rescued by PI3K inhibitor LY294002 treatment. Collectively, our results here elucidate that G3BP1‐depletion suppresses proliferation, migration, and invasion capabilities of esophageal cancer cells via the inactivation of Wnt/β‐catenin and PI3K/AKT signaling pathways. Furthermore, our findings imply that G3BP1 can participate in the regulation of esophageal cancer progression, and will be taken as a promising target to treat esophageal cancer.